New Hepatitis B Testing Guidelines Include Universal Adult Screening
Drug Topics
APRIL 17, 2023
The CDC said that the new guidance will help identify more cases earlier for better treatment outcomes.
Drug Topics
APRIL 17, 2023
The CDC said that the new guidance will help identify more cases earlier for better treatment outcomes.
PharmaVoice
APRIL 17, 2023
Gain a deep understanding of the analytical challenges that gene therapy developers face, and how a strategic partnership with a specialized CRO can offer a competitive advantage in accelerating timelines and improving program success.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
APRIL 17, 2023
At the 44th National Association of Pediatric Nurse Practitioners Conference, a session presented data explaining why teenagers with T1D are at high risk for developing anorexia and bulimia.
PharmaVoice
APRIL 17, 2023
As social media health influencers enter the world of pharma advertising, experts warn that more guardrails are needed to protect the industry and patients.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
APRIL 17, 2023
At the 44th annual National Association of Pediatric Nurse Practitioners Conference, the CDC provided an updated immunization schedule that details new changes.
Pharmacy Times
APRIL 17, 2023
The efficacy and tolerability of rizatriptan for acute migraine treatment has been well established.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
APRIL 17, 2023
Other health essentials, such as groceries, prescriptions, some OTC medications, are tax-exempt in many states.
Drug Topics
APRIL 17, 2023
The drug is the first and only therapy to delay the onset of stage 3 type 1 diabetes.
Pharmacy Times
APRIL 17, 2023
The 2 most hypervirulent strains of Clostridioides difficile are associated with the consumption of pork and shellfish.
Fierce Healthcare
APRIL 17, 2023
14M people could lose dental coverage as Medicaid redeterminations restart: report pminemyer Mon, 04/17/2023 - 15:58
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmacy Times
APRIL 17, 2023
Some classes and curricula can contribute to preexisting stigmas about drugs and treatments for mental health.
Fierce Healthcare
APRIL 17, 2023
HHS releases free online cybersecurity training, best practice reports for healthcare dmuoio Mon, 04/17/2023 - 15:49
Pharmacy Times
APRIL 17, 2023
Although payers have become somewhat accustomed to the high cost of specialty drugs, the price tags for gene therapies are causing “sticker shock.
Fierce Healthcare
APRIL 17, 2023
CVS taps former Humana exec Brian Kane to lead Aetna pminemyer Mon, 04/17/2023 - 16:57
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
APRIL 17, 2023
The data support the use of interventions at home, including frequent handwashing, physical distancing, regular surface disinfection, and wearing a mask.
Drug Store News
APRIL 17, 2023
According to a Wall Street Journal report, Redfield will leave the role on May 1, and the company will announce his replacement soon.
Pharmacy Times
APRIL 17, 2023
According to 5-year follow-up data, the combination of tafasitamab-cxix and lenalidomide produced a durable response in patients with diffuse large B-cell lymphoma.
European Pharmaceutical Review
APRIL 17, 2023
Merck & Co. Inc has agreed to acquire Prometheus Biosciences for $10.8 billion. The agreement is set to help advance PRA023, a novel humanised monoclonal antibody (mAb), developed by Prometheus. Its chosen indications are ulcerative colitis (UC) and Crohn’s disease (CD) and other autoimmune conditions. Prometheus is a clinical-stage biotechnology company.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Fierce Healthcare
APRIL 17, 2023
HIMSS23: Philips, Intermountain executives call for tech partnerships focused on thoughtful innovation to address burnout aburky Mon, 04/17/2023 - 18:20
Pharmaceutical Technology
APRIL 17, 2023
Merck has signed a definitive agreement to buy clinical-stage biotechnology firm Prometheus Biosciences for $10.8bn, strengthening its immunology pipeline. The company will buy all of Prometheus Biosciences’ outstanding shares for $200 a share through a subsidiary. Prometheus Biosciences uses precision medicine to discover, develop and commercialise new therapeutic and companion diagnostic products to treat immune-mediated diseases.
Drug Store News
APRIL 17, 2023
General Mills is surprising fans with a new collection of items ranging from new cereals to cereal-inspired snacks.
PharmExec
APRIL 17, 2023
J&J's Janssen Pharmaceutica NV collaborates with Pipeline Therapeutics in a $50 million licensing deal for oral MS drug PIPE-307, with potential earnings of up to $1 billion for Pipeline.
Drug Store News
APRIL 17, 2023
Said Darwazah will step down as acting CEO and return to his role as executive chairman.
STAT
APRIL 17, 2023
In an attempt to make naloxone more accessible amid the massive human toll of the opioid crisis, the FDA recently approved over-the-counter naloxone. Naloxone is the one solution that has remained constant through the evolving opioid crisis. A safe and effective medication that can quickly reverse an overdose, it is a critical tool in the public health response to the opioid crisis.
Drug Store News
APRIL 17, 2023
Pharmacy is having a moment, and it’s coming at a critical time.
STAT
APRIL 17, 2023
Frank David was just starting an independent research program on cell signaling in cancer and kidney development at a lab in Boston when he realized he’d rather be doing something else. “I figured out I was more interested in how science turned into medicine than I was in actually making and discovering new science,” he recalled.
Drug Store News
APRIL 17, 2023
Bucked Up’s Pixie Pump leverages natural ingredients to deliver long-lasting energy and focus, the company said.
Fierce Pharma
APRIL 17, 2023
In Pfizer's $43B acquisition of Seagen, the biotech's patience paid off kdunleavy Mon, 04/17/2023 - 11:34
Fierce Healthcare
APRIL 17, 2023
HIMSS23: Epic taps Microsoft to integrate generative AI into EHRs with Stanford, UC San Diego as early adopters hlandi Mon, 04/17/2023 - 10:13
Pharmaceutical Technology
APRIL 17, 2023
NKGen Biotech, a clinical-stage natural killer (NK) cell therapy firm, has signed a definitive agreement to combine its business operations with Graf Acquisition. NKGen Biotech will become a publicly traded company, while Graf will be rebranded as NKGen Biotech. Graf is also anticipated to be listed on the New York Stock Exchange, NYSE American and Nasdaq under the ticker symbol ‘NKGN’.
STAT
APRIL 17, 2023
Genetic engineering has the potential to transform how we raise animals for meat and other products, making food safer, improving animal health and welfare, and shrinking animal agriculture’s environmental footprint. Pigs that are less likely to induce allergic reactions in humans. Cows with short hair that are better adapted to a changing climate or others that lack horns , preventing injury to other cows or farmhands.
The Checkup by Singlecare
APRIL 17, 2023
If you are one of the 80% to 90% of adults who start your day with a cup of coffee, it’s likely you will encounter caffeine withdrawal at one time or another. Caffeine withdrawal usually occurs when you quit caffeine “cold turkey” and can cause unpleasant symptoms—one of the most common being a caffeine withdrawal headache. Some people with caffeine dependence get headaches if they miss their daily Starbucks latte by even an hour.
STAT
APRIL 17, 2023
For patients of the Community of Hope and Mary’s Center clinics in Washington, D.C., getting to their medical appointments can be a challenge — many live far from public transit or lack cars. If they’re pregnant, the fallout can be especially harmful if they miss prenatal doctor visits, risking the baby’s and mother’s health.
Let's personalize your content